WHO-GMP Certified Commercial Pack · Product Code: AKP-060
Piroxicam 20mg Injection (per ml)
Formulation Overview: Long-half-life oxicam NSAID intramuscular solution delivering sustained 24-hour anti-inflammatory analgesia from a single daily acute-care dose. Formulated with Piroxicam USP / IP 20 mg (per ml) (20 mg / 1 ml) in Sterile Liquid Injection Ampoule dosage form under Pain, Inflammation & NSAIDs, manufactured to IP / BP / USP Compendial standards and supplied in 5 x 1 ml / 5 x 2 ml Amber USP Type I Glass Ampoules with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-060 |
|---|---|
| Therapeutic Sector | Pain, Inflammation & NSAIDs |
| Dosage Form | Sterile Liquid Injection Ampoule |
| Active Ingredient | Piroxicam USP / IP 20 mg (per ml) |
| Strength / Purity | 20 mg / 1 ml |
| Clinical Indication | Acute rheumatoid flare-ups, ankylosing spondylitis, acute gout, and intense postoperative musculoskeletal pain |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 5 x 1 ml / 5 x 2 ml Amber USP Type I Glass Ampoules |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; protect from light |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |